Provided by Tiger Fintech (Singapore) Pte. Ltd.

Silexion Therapeutics Corp

9.28
-5.6600-37.88%
Post-market: 9.300.0200+0.22%19:58 EDT
Volume:360.35K
Turnover:3.35M
Market Cap:5.21M
PE:-0.02
High:11.10
Open:11.10
Low:7.82
Close:14.94
Loading ...
Nov 22, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Nov 19, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 31, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Oct 15, 2024

Correspondence

Form CORRESP - Correspondence
Oct 09, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Oct 01, 2024

Major Issues Report

Form 8-K - Current report
Sep 24, 2024

Major Issues Report

Form 8-K - Current report
Sep 19, 2024

Major Issues Report

Form 8-K - Current report
Sep 17, 2024

Correspondence

Form CORRESP - Correspondence
Sep 10, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 22, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Aug 22, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Aug 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 26, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations